The Justice Department has been appealing the deal, approved earlier this month.
The Purdue Pharma bankruptcy case settlement protected the wealthy and ignored those who suffered.
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.
In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are granted broad legal immunity.
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.
The ruling was a milestone in yearslong efforts to make the OxyContin manufacturer pay for its role in the opioid crisis, but some plaintiffs feel the plan doesn’t go far enough.
Five articles from around The Times, narrated just for you.
The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.
One activist is asking the Biden administration to remember the failures that led to the opioid epidemic as it chooses the next head of the F.D.A.
The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.
It was the first time in years that members of the family that owns Purdue Pharma have taken questions publicly, and the exchanges were tense.
A trapdoor in the Justice Department deal with the family’s company might enable them to escape a full accounting of their part in the opioid epidemic.
Court filings reveal consultants’ talk of a records purge during the opioid crisis, and shed new light on sales advice given to the billionaire Sackler family and their drug company, Purdue Pharma.
The admission in federal court brought a formal end to a major investigation that resulted in a multibillion-dollar settlement between the drug maker and the government.
The company, which produced OxyContin, faces penalties of $8.3 billion. But families of those addicted are skeptical of the tangible benefits.
The family behind Purdue Pharma made a fortune on the opioid epidemic. Will they ever truly face justice?